Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review

Ann Lab Med. 2023 May 1;43(3):299-302. doi: 10.3343/alm.2023.43.3.299. Epub 2022 Dec 22.
No abstract available

Publication types

  • Review
  • Letter

MeSH terms

  • Antibodies, Viral
  • ChAdOx1 nCoV-19*
  • Female
  • Humans
  • Prevalence
  • Vaccination* / adverse effects

Substances

  • ChAdOx1 nCoV-19
  • Antibodies, Viral